CLL

Conference Coverage

Comparing BTKis Acalabrutinib and Ibrutinib in Real-World Analysis of Patients With CLL

12/12/2022

Craig Ostroff

At the 64th ASH Annual Meeting and Exposition, Lindsey E Roeker, MD, and colleagues present a real-world analysis comparing CV and bleeding AEs as well as PFS in patients with CLL treated with acalabrutinib vs those treated with ibrutinib.

At the 64th ASH Annual Meeting...

12/12/2022

Journal of Clinical Pathways

Videos

Real-World Ibrutinib Dose Reductions, Discontinuations in CLL

03/11/2021

Jing-Zhou Hou, MD, PhD, discusses dose reductions and discontinuations between patients with CLL receiving ibrutinib in the community vs academic settings.

Jing-Zhou Hou, MD, PhD,...

03/11/2021

Journal of Clinical Pathways

Periorbital Richter Syndrome

01/06/2015

Publisher:Open Science Company, LLC
Mark Gorman, MRCS, MSc, Julia Ruston, MRCS, and Sarath Vennam, BMBS

Publisher:Open Science Company, LLCMa...

Periorbital Richter Syndrome Mark Gorman, MRCS, MSc,a Julia Ruston, MRCS,b and Sarath Vennam, BMBSa aDivision of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon, United Kingdom; and bDivision of Plastic Surgery,...

Periorbital Richter...

01/06/2015

ePlasty